These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 22104220)

  • 1. [Relationship between the genetic polymorphisms of phase I and II drug-metabolizing enzymes, as well as the outcome of chemotherapy in advanced non-small cell lung cancer].
    Li W; Yue W; Yang X; Zhang C; Wang Y
    Zhongguo Fei Ai Za Zhi; 2011 Nov; 14(11):858-64. PubMed ID: 22104220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphisms in GSTM1, CYP1A1, CYP2E1, and CYP2D6 are associated with susceptibility and chemotherapy response in non-small-cell lung cancer patients.
    Li W; Yue W; Zhang L; Zhao X; Ma L; Yang X; Zhang C; Wang Y; Gu M
    Lung; 2012 Feb; 190(1):91-8. PubMed ID: 22109568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Combined effects of genetic polymorphisms in cytochrome P450s and GSTM1 on lung cancer susceptibility].
    Gu YF; Zhang ZD; Zhang SC; Zheng SH; Jia HY; Gu SX
    Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(43):3064-8. PubMed ID: 18261353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GSTM1, GSTP1, CYP1A1 and CYP2D6 polymorphisms in lung cancer patients from an environmentally polluted region of Poland: correlation with lung DNA adduct levels.
    Butkiewicz D; Cole KJ; Phillips DH; Harris CC; Chorazy M
    Eur J Cancer Prev; 1999 Aug; 8(4):315-23. PubMed ID: 10493307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic polymorphisms of metabolic enzymes-CYP1A1, CYP2D6, GSTM1, and GSTT1, and gastric carcinoma susceptibility.
    Luo YP; Chen HC; Khan MA; Chen FZ; Wan XX; Tan B; Ou-Yang FD; Zhang DZ
    Tumour Biol; 2011 Feb; 32(1):215-22. PubMed ID: 20878561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The relationship between genetic polymorphism of metabolizing enzymes and the genetic susceptibility to lung cancer].
    Li WY; Lai BT; Zhan XP
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Dec; 25(12):1042-5. PubMed ID: 15769360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of CYP1A1, GSTM1 and GSTT1 gene polymorphisms with risk of non-small cell lung cancer in Andhra Pradesh region of South India.
    Peddireddy V; Badabagni SP; Gundimeda SD; Mamidipudi V; Penagaluru PR; Mundluru HP
    Eur J Med Res; 2016 Apr; 21():17. PubMed ID: 27090234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between genetic polymorphisms of drug-metabolizing enzymes (CYP1A1, CYP2E1, GSTM1, and NAT2), drinking habits, histological subtypes, and p53 gene point mutations in Japanese patients with gastric cancer.
    Suzuki S; Muroishi Y; Nakanishi I; Oda Y
    J Gastroenterol; 2004; 39(3):220-30. PubMed ID: 15064998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk for K-ras gene mutations in smoking-induced lung cancer is associated with cytochrome P4501A1 and glutathione S-transferase micro1 polymorphisms.
    Noda N; Matsuzoe D; Konno T; Kawahara K; Yamashita Y; Shirakusa T
    Oncol Rep; 2004 Oct; 12(4):773-9. PubMed ID: 15375499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Xenobiotic/drug metabolizing enzyme and TP53 polymorphisms and clinical outcome in advanced nonsmall cell lung cancer patients.
    Karacaoğlan V; Ada AO; Bilgen S; Çetinkaya GT; Soydaş E; Kunak CS; Alpar SM; Gülhan M; Işcan M
    Turk J Med Sci; 2017 Apr; 47(2):554-562. PubMed ID: 28425245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CYP1A1, CYP2E1 and GSTM1 genetic polymorphisms. The effect of single and combined genotypes on lung cancer susceptibility in Chilean people.
    Quiñones L; Lucas D; Godoy J; Cáceres D; Berthou F; Varela N; Lee K; Acevedo C; Martínez L; Aguilera AM; Gil L
    Cancer Lett; 2001 Dec; 174(1):35-44. PubMed ID: 11675150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of GSTM1, CYP1A1 and CYP2E1 genetic polymorphisms with susceptibility to lung adenocarcinoma: a case-control study in Chinese population.
    Wang J; Deng Y; Li L; Kuriki K; Ding J; Pan X; Zhuge X; Jiang J; Luo C; Lin P; Tokudome S
    Cancer Sci; 2003 May; 94(5):448-52. PubMed ID: 12824892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytochrome P450 1A1, 2E1 and GSTM1 gene polymorphisms and susceptibility to colorectal cancer in the Saudi population.
    Saeed HM; Alanazi MS; Nounou HA; Salaby MA; Semlali A; Azzam N; Aljebreen A; Alharby O; Parine NR; Shaik J; Arafaha M
    Asian Pac J Cancer Prev; 2013; 14(6):3761-8. PubMed ID: 23886179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of CYP2D6, CYP1A1, CYP2E1, GSTT1, and GSTM1 genes in the susceptibility to acute leukemias.
    Aydin-Sayitoglu M; Hatirnaz O; Erensoy N; Ozbek U
    Am J Hematol; 2006 Mar; 81(3):162-70. PubMed ID: 16493615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colorectal cancer risk in relation to genetic polymorphism of cytochrome P450 1A1, 2E1, and glutathione-S-transferase M1 enzymes.
    Kiss I; Sándor J; Pajkos G; Bogner B; Hegedüs G; Ember I
    Anticancer Res; 2000; 20(1B):519-22. PubMed ID: 10769717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Genetic and phenotypic polymorphisms in carcinogen-metabolizing enzymes and cancer susceptibility].
    Watanabe M
    Nihon Rinsho; 1996 Aug; 54(8):2261-75. PubMed ID: 8810806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined analysis of germline polymorphisms of p53, GSTM1, GSTT1, CYP1A1, and CYP2E1: relation to the incidence rate of cervical carcinoma.
    Kim JW; Lee CG; Park YG; Kim KS; Kim IK; Sohn YW; Min HK; Lee JM; Namkoong SE
    Cancer; 2000 May; 88(9):2082-91. PubMed ID: 10813720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic polymorphism of the CYP1A1, CYP2E1, GSTM1 and GSTT1 genes and lung cancer susceptibility in a north indian population.
    Sobti RC; Sharma S; Joshi A; Jindal SK; Janmeja A
    Mol Cell Biochem; 2004 Nov; 266(1-2):1-9. PubMed ID: 15646021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic polymorphisms of CYP1A1, GSTM1 and GSTT1 genes and lung cancer risk.
    Dialyna IA; Miyakis S; Georgatou N; Spandidos DA
    Oncol Rep; 2003; 10(6):1829-35. PubMed ID: 14534704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p53 mutation spectrum in relation to GSTM1, CYP1A1 and CYP2E1 in surgically treated patients with non-small cell lung cancer.
    Przygodzki RM; Bennett WP; Guinee DG; Khan MA; Freedman A; Shields PG; Travis WD; Jett JR; Tazelaar H; Pairolero P; Trastek V; Liotta LA; Harris CC; Caporaso NE
    Pharmacogenetics; 1998 Dec; 8(6):503-11. PubMed ID: 9918134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.